Concepedia

Xiamei Zhang

XZ

16

Publications

1.3K

Citations

15

H-Index

2001

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Biogen (United States)

University of Pennsylvania

Biogen (Switzerland)

Xiamei Zhang is an author at Harvard University specializing in medicine, inorganic chemistry, and chemical engineering.

Top concepts

Publications per year

2001–2021

16

Publications

16

IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism

Alexandra Grassian, Seth J. Parker, Shawn M. Davidson et al. · Cancer Research · 2014 · 285 citations · Full text

Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

Chen Liu, Hengyu Lu, Hongyun Wang et al. · Clinical Cancer Research · 2020 · 156 citations · Full text

Characterization of NorR Protein, a Multifunctional Regulator of <i>norA</i> Expression in <i>Staphylococcus aureus</i>

Q. C. Truong-Bolduc, Xiamei Zhang, David C. Hooper · Journal of Bacteriology · 2003 · 137 citations · Full text

, , +20

A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth <i>In vivo</i> and Prevents Tumor Recurrence after Surgical Resection

Eiji Suzuki, Samuel Kim, Hung Kam Cheung et al. · Cancer Research · 2007 · 113 citations

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Kai Fu, Michael J. Corbley, Lihong Sun et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 84 citations · Full text

Rows per page

1–5 of 16